ATIF BEN COLLINS
Allopathic & Osteopathic Physicians|Ophthalmology|Ophthalmic Plastic and Reconstructive Surgery FRESNO, CA NPI 1891010948
Browse related groups: Allopathic & Osteopathic Physicians|Ophthalmology|Ophthalmic Plastic and Reconstructive Surgery CA Amgen Inc. All categories
General Payments — all program years on this page
$707.47
- Category: General Payments
- Program years: PY2019–2024
- Record count: 14
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $309.11 across 10 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $309.11 | 10 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $276.32 | 8 |
| Galderma Laboratories, L.P. | $16.42 | 1 |
| ABBVIE INC. | $16.37 | 1 |
By program year
Records — PY2024 (10)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1103491591 | ABBVIE INC. | $16.37 | 10/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1111552756 | Amgen Inc. | $115.82 | 05/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1111552758 | Amgen Inc. | $11.92 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1111552760 | Amgen Inc. | $27.61 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1111552762 | Amgen Inc. | $23.90 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1111552764 | Amgen Inc. | $22.90 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1111552766 | Amgen Inc. | $30.06 | 11/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1111552768 | Amgen Inc. | $21.06 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1111552770 | Amgen Inc. | $23.05 | 12/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1145291607 | Galderma Laboratories, L.P. | $16.42 | 09/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.